Metastasis
From Anvita Health Wiki
Contents |
More Specific Terms
- bone metastases
- brain metastases
- carcinomatous meningitis (leptomeningeal metastases)
- drop metastases
- liver metastases
- lymph node metastases
- pulmonary metastases
Introduction
- Patterns of metastases of common cancers (see etiology)
Etiology
- metastasis to lymph nodes
- breast cancer(60-80%)
- lung cancer (83% local, 29% distant)
- prostate cancer (68%)
- melanoma (58%)
- ovarian cancer (48% local, 58% distant)
- colorectal carcinoma (53%)
- metastasis to liver
- lung cancer (73%)
- melanoma (63%)
- breast cancer (40-60%)
- ovarian cancer (48%)
- colorectal carcinoma (44%)
- kidney cancer (44%)
- prostate cancer (36%)
- metastasis to lung
- kidney cancer (72%)
- breast cancer (66%)
- melanoma (60%)
- prostate cancer (49%)
- ovarian cancer (34%)
- colorectal carcinoma (16%)
- ipsilateral or contralateral lung cancer (8%)
- thyroid cancer
- head & neck cancer
- prostate cancer (67%)
- breast cancer (62%)
- lung cancer (56%)
- melanoma (48%)
- colorectal carcinoma (27%)
- bladder cancer (26%)
- cervical cancer (21%)
- ovarian cancer (12%)
- kidney cancer (10%)
- lung cancer (37-50%)
- breast cancer (10-23%)
- melanoma (10-48%)
- kidney cancer (19%)
- colorectal carcinoma (11%)
- cervical cancer (9%)
- bladder cancer (7%)
- ovarian cancer (3%)
- prostate cancer (2%)
- metastasis to skin
- melanoma (44%)
- breast cancer (20%)
- colorectal carcinoma (5%)
- bladder cancer (5%)
- kidney cancer (5%)
- ovarian cancer (5%)
- cervical cancer (3%)
- prostate cancer (3%)
- metastasis to adrenal
- melanoma (48%)
- lung cancer (35%)
- bladder cancer (35%)
- colorectal carcinoma (31%)
- breast cancer (31%)
- cervical cancer (31%)
- kidney cancer (20%)
- ovarian cancer (20%)
- prostate cancer (17%)
- metastasis to kidney
- melanoma (27%)
- cervical cancer (26%)
- ipsilateral or contralateral kidney cancer (21%)
- bladder cancer (19%)
- breast cancer (17%)
- lung cancer (16%)
- colorectal carcinoma (13%)
- prostate cancer (11%)
- ovarian cancer (6%)
Pathology
- relatively few malignant cells shed by primary tumors metastasize successfully
- either the malignant cells do not enter distant organs, or they enter but fail to multiply
- only malignant stem cells may successfully metastasize [3]
- malignant stem cells attach to endothelial cells in the target organ's microcirculation, then invade the stroma
- in the stroma, the malignant stem cells induce fibroblasts to produce periostin ( breast cancer metastasis) [3]
Genetics
- abnormalities of alpha-catenin are involved in the process of cancer invasion & metastasis
Complications
Management
-
- a single brain metastasis may be amenable to surgical resection
- multiple brain metastases are treated palliatively
More General Terms
Additional Terms
- down-regulated in metastasis protein (key-1A6 protein, novel nucleolar protein 73, NNP73, DRIM)
- metastasis-associated protein MTA2 (metastasis-associated 1-like 1, MTA1-L1 protein, p53 target protein in deacetylase complex, MTA2, MTA1L1, PID)
References
- Harrison's Principles of Internal Medicine, 14th ed. Fauci et al (eds), McGraw-Hill Inc. NY, 1998, pg 521
- Medical Knowledge Self Assessment Program (MKSAP) 15, American College of Physicians, Philadelphia 2009
- Journal Watch Komaroff AL New Insights into the Biology of Metastasis Journal Watch February 1, 2012 Massachusetts Medical Society
- Malanchi I et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 2011 Dec 7; 481:85. PMID: [1]
- Png KJ et al. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 2011 Dec 14; 481:190. PMID: [2] - NCI: Metastatic Cancer; Questions & Answers [3]
- National Guideline Clearinghouse Follow-up of malignant or aggressive musculoskeletal tumors. ngc-guideline: [4]
- ACR Appropriateness Criteria for metastatic bone disease ngc-guideline: [5]
- Screening for pulmonary metastases. American College of Radiology ngc-guideline: [6]
- Leptomeningeal metastases. Association of Comprehensive Cancer Centres ngc-guideline: [7]
- Metastatic malignant disease of unknown primary origin. Diagnosis and management of metastatic malignant disease of unknown primary origin. National Collaborating Centre for Cancer ngc-guideline: [8]
